Wholesale USA Cigarettes Online

Phone: (+1)347-329-5088
Email: alisa086@yahoo.com
Skype: alisa.lee01


Tobacco can be made into cigarette, dry tobacco, pipe tobacco and cigar for human consumption. Besides, it has many medical uses. Although tobacco has brought a lot of harm to human beings, even known as "poisonous weeds", many countries or regions have explicitly restricted the circulation or smoking. Who members have also signed the Framework Convention on tobacco control. However, as a kind of medicinal plant with a long history, its medical value can not be erased because of its harmfulness. According to the national collection of Chinese herbal medicine, tobacco is warm, sweet and poisonous, and has the effects of detumescence, detoxification and insecticidal effect. It is mainly used for the treatment of sores, tinea capitis, tinea albuginea, alopecia, snakebite and other diseases, as well as neck gangrene, back carbuncle, wind phlegm, crane knee (including bone tuberculosis, chronic suppurative knee arthritis, etc.). It can also be used to kill "four pests" (Oncomelania hupensis, mosquitoes, flies, mice) and insecticidal. Researchers at La Trobe University in Australia have found a new protein compound NaD1 in Nicotiana alata that kills cancer cells without damaging healthy cells, according to a study published by researchers at La Trobe University in Australia. NaD1 uses its sharp pincers to stick into the macromolecules on the outer membrane of cancer cells, tearing apart cancer cells, tearing out the contents of the cells and destroying them before they can spread the cancer to other cells. "It's ironic that this powerful anti-cancer mechanism is embedded in the flowers of ornamental tobacco crops, but we welcome it no matter how it comes from. "The team's lead researcher, Dr. mark Hulett, said. Researchers already know how the protein works, and they're working on how to put NaD1 into practical anti-cancer drugs. The protein is in preclinical trials at a biopharmaceutical company in Melbourne, but Hulett said it would be about a decade before the drug could enter hospitals.